ES2747993T8 - Composiciones farmacéuticas de liberación prolongada de levetiracetam - Google Patents
Composiciones farmacéuticas de liberación prolongada de levetiracetamInfo
- Publication number
- ES2747993T8 ES2747993T8 ES16728462T ES16728462T ES2747993T8 ES 2747993 T8 ES2747993 T8 ES 2747993T8 ES 16728462 T ES16728462 T ES 16728462T ES 16728462 T ES16728462 T ES 16728462T ES 2747993 T8 ES2747993 T8 ES 2747993T8
- Authority
- ES
- Spain
- Prior art keywords
- levetiracetam
- extended
- pharmaceutical compositions
- release pharmaceutical
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000013265 extended release Methods 0.000 title 1
- HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical group CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 title 1
- 229960004002 levetiracetam Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562165812P | 2015-05-22 | 2015-05-22 | |
| PCT/US2016/033567 WO2016191288A1 (en) | 2015-05-22 | 2016-05-20 | Extended release pharmaceutical compositions of levetiracetam |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2747993T3 ES2747993T3 (es) | 2020-03-12 |
| ES2747993T8 true ES2747993T8 (es) | 2021-03-30 |
Family
ID=61223552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16728462T Active ES2747993T3 (es) | 2015-05-22 | 2016-05-20 | Composiciones farmacéuticas de liberación prolongada de levetiracetam |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3297611B1 (es) |
| DK (1) | DK3297611T3 (es) |
| ES (1) | ES2747993T3 (es) |
| MA (1) | MA50634A (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4504176A1 (en) * | 2022-04-01 | 2025-02-12 | Agenebio, Inc. | Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040191803A1 (en) | 2002-11-22 | 2004-09-30 | Michela Gallagher | Target for therapy of cognitive impairment |
| EP2682481A3 (en) | 2005-08-03 | 2014-09-17 | The Johns-Hopkins University | Methods for characterizing and treating cognitive impairment in aging and disease |
| US20080014271A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
| ES2865504T3 (es) * | 2008-10-16 | 2021-10-15 | Univ Johns Hopkins | Procedimientos y composiciones para la mejora de la función cognitiva |
| KR20120055313A (ko) * | 2010-11-23 | 2012-05-31 | 주식회사 바이오파마티스 | 레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법 |
| DE102011103270A1 (de) * | 2011-05-26 | 2012-11-29 | Stada Arzneimittel Ag | Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten |
| JP6433482B2 (ja) * | 2013-03-15 | 2018-12-05 | エージンバイオ, インコーポレイテッド | 認知機能を改善するための方法および組成物 |
-
2016
- 2016-05-20 DK DK16728462.9T patent/DK3297611T3/da active
- 2016-05-20 EP EP16728462.9A patent/EP3297611B1/en active Active
- 2016-05-20 EP EP19175798.8A patent/EP3590506A1/en active Pending
- 2016-05-20 MA MA050634A patent/MA50634A/fr unknown
- 2016-05-20 ES ES16728462T patent/ES2747993T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2747993T3 (es) | 2020-03-12 |
| MA50634A (fr) | 2021-04-28 |
| EP3590506A1 (en) | 2020-01-08 |
| DK3297611T3 (da) | 2019-09-02 |
| EP3297611B1 (en) | 2019-07-03 |
| EP3297611A1 (en) | 2018-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3493799A4 (en) | CANNABIS | |
| DK3256138T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| MA44702A (fr) | Compositions de suspension à libération prolongée | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| DK3655017T3 (da) | Farmaceutisk sammensætning | |
| DK3253382T3 (da) | Farmaceutiske sammensætninger til kombinationsterapi | |
| EP3493798A4 (en) | CANNABIS | |
| EP3454899C0 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3364944C0 (en) | PHARMACEUTICAL COMPOSITIONS OF IL-2 | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| EP3334726A4 (en) | PINABULIN COMPOSITIONS | |
| IL287520A (en) | Levetiracetam extended-release pharmaceutical preparations | |
| EP3310439A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| SI3424499T1 (sl) | Farmacevtski sestavek za nevropatsko bolečino | |
| JO3456B1 (ar) | فيروتيوكسيتين بيروجلوتامات | |
| MA49837A (fr) | Compositions pharmaceutiques | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| DK3728220T3 (da) | Farmaceutiske forbindelser | |
| SMT202400478T1 (it) | Composizione farmaceutica | |
| EP3646863A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3524250A4 (en) | PHARMACEUTICAL COMPOSITION | |
| DK3288933T3 (da) | Oxindolforbindelser og farmaceutiske sammensætninger deraf |